Objective: To determine the nature and quality of the physiologic evid
ence regarding an ''optimum'' hemoglobin concentration in anemic patie
nts or in patients with specific diseases. Literature search and selec
tion: Searches of MEDLINE from January 1966 to December 1996 were comb
ined with manual searches of the bibliographies and references from ex
perts. Citations were chosen by 2 reviewers if they were related to re
d blood cell transfusion practice and, more specifically, to physiolog
ic adaptation to anemia. Disagreement was resolved through consensus.
Literature synthesis: The articles selected from the literature search
were classified by study design and topic areas. Evidence-based infer
ences were derived from the literature. Results: Of the 160 articles i
ncluded in this review, 58 (36%) were human studies and 102 (64%) were
laboratory studies. Most studies (84) fell into the ''hemodilution''
category, and were predominantly in animal models (70). Overall, 90 st
udies (56%) used a valid design with appropriate experimental and conc
urrent control groups (graded as level I or II). The distribution of g
rading was uniform throughout the categories. The quality of the evide
nce was deemed weaker for laboratory studies evaluating cardiac adapta
tion to anemia, largely because of a lack of reported concurrent contr
ols in most studies. Inferences drawn from the literature were graded
on a 4-point scale assessing the quality of the evidence; 13 of 18 sta
tements were given the highest grade. The clinical significance of the
Bohr effect and the shifts in the oxyhemoglobin curve following chang
es in pH were thought to be poorly studied and were rated lowest. The
studies evaluating maximum oxygen delivery in anemia were rated as wea
k, partly because of conflicting reports. Of all identified studies, 5
6% were well designed and reported. Important adaptive responses to an
emia consist of an elevation of cardiac output and its redistribution
to favour the coronary and cerebral circulations at the expense of the
splanchnic vascular beds; studies supporting these statements were ra
ted highly. The evidence also suggests that patients with cardiac dise
ase are at risk of adverse events from anemia. Conclusions: There is a
significant body of evidence supporting cardiovascular adaptive respo
nses to anemia. However, there is a remarkable lack, in both quality a
nd quantity, of clinical studies addressing how the ''normal'' physiol
ogic adaptations may be affected by a variety of diseases. The physiol
ogic evidence alone is insufficient to inform most decisions about red
brood cell transfusion.